7 | ACRFY Financials 07/16/2014 00:12:20 Accor SA | Emylers | 07/16/2014 1:12:17 AM |
6 | Latest Accor S A Unsp ADR (ACRFY) Headlines OTC | Stock_Tracker | 03/08/2014 4:48:22 PM |
5 | ACRFY 10.346 Stock Charts $ACRFY 1 Month Chart | chartguy89 | 03/05/2014 6:22:06 PM |
4 | ACRFY Recent News OTC Selector Stock Watch - | Stock_Tracker | 03/02/2014 1:49:51 AM |
3 | ACRFY Stock Charts Saturday, February 22, 2014 at | chartguy89 | 02/22/2014 1:23:54 AM |
2 | ACRFY Stock Chart 9.90 Saturday, February 8, 2014 | chartguy89 | 02/08/2014 12:45:31 AM |
1 | ACRFY Accor S.A. operates in hotels and services | Stock Buff | 04/12/2013 7:45:14 PM |
Recent Articles
- Howard Lutnick Discusses Upcoming Chip Import Probe Results
- Lleida.net Achieves Remarkable 33% Growth in Q2 2025 EBITDA
- RESVION Expands Its Portfolio with Tremonia Mobility Acquisition
- SCO Summit in China: Cultivating Unity and Collaboration
- FORVIA H1 2025: Insights on Growth and Strategic Changes
- Roche Advances Alzheimer’s Innovations with Groundbreaking Data
- Innovative Collaboration Between EnduroSat and WISeSat.Space
- Heineken N.V. Achieves Strong Growth in Half-Year Results
- Heineken Holding N.V. Shows Robust Growth in Half-Year Results
- BW Energy Expands Operations with Deepsea Mira Contract
- Bitcoin's Astounding Growth: Chamath's 2013 Call Wins Big
- Heineken N.V. Achieves Strong Half-Year Results for 2025
- FORVIA Reports Strong Half-Year Results and Confirms Guidance
- Heineken Holding N.V. Shows Commitment with Strong Half-Year Performance
- Ambassador Linda Thomas-Greenfield Joins Rendeavour's Vision
- Kalaam Telecom and SecurityHQ Join Forces for Cybersecurity Growth
- Steve Eisman's Take on Opendoor's Soaring Stock Price
- Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
- Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
- Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
- Exploring the Success of CBD Fair Guangzhou's 2025 Edition
- Economic Impact of Trump's Trade Deal: What Comes Next?
- Antengene Prepares for Major Presentation on ATG-022 at ESMO
- How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
- Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
- Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
- US and China Seek Trade Solutions Amid Tariff Tensions
- Introducing Automate's Push PRO: Revolutionary Shade Control
- Exciting Esports World Cup Promotion from JBO Thailand
- Harbour BioMed Unveils Strong Profit Predictions for Future Growth
- Ascletis Begins Significant Obesity Study with ASC30 Drug
- Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
- Perseus Mining's Operational Highlights and Financial Overview
- Shara Magomedov Shines at UFC Night with Epic Victory
- Investors Urged to Participate in Class Action Against Centene
- Exploring America’s Hidden Resource Potential and Technology
- Trump's New Tariff Deal with EU: Impacts and Insights
- Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
- Empowering Hims & Hers Health Shareholders: Your Legal Guide
- Public Sentiment on Trump's Tax Cuts: A Closer Look
- Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
- Easterly ROCMuni Fund Class Action: Investor Rights Explained
- Class Action Alert: RxSight Investors Take Action Against Losses
- Investors of iRobot Corporation Urged to Act Before Deadline
- Dustin Moskovitz Expands Asana Holdings with Major Purchase
- Navigating High-Stress Careers: Insights from Executives
- Banco Comercial Português Updates on Share Buy-Back Programme Activity
- Centene Corporation Faces Class Action Over Investor Losses
- Banco Comercial Português (BCP) Shares Buy-Back Program Update
- Insights into Gilead Sciences, Inc. and Recent Developments